microbiome therapeutics

News

The MHRA has published its position paper clarifying how microbiome-based medicines can be made available for patients in the UK.

Events

Partner Content

Discover the Next Generation of Microbiome Therapeutics

News

Sandoz said today it intends to double net sales between 2025 and 2035, fuelled by an acceleration in biosimilar medicine development.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.